Noguchi Memorial Institute For Medical Research

This study aims to see if giving a combination of malaria drugs (DHAP and primaquine) to everyone in high-risk communities can reduce malaria infections and stop the disease from spreading. About 9,000 people aged 3 months and older will receive the drugs every two months for a y…